Intravenous ferric carboxymaltose treatment in cancer patients.

被引:0
|
作者
Aslan, Alma [1 ]
Tasdemir, Vildan [1 ]
Kertmen, Neyran [1 ]
Dizdar, Omer [1 ]
Aksoy, Sercan [1 ]
机构
[1] Hacettepe Univ, Dept Med Oncol, Canc Inst, Ankara, Turkey
关键词
D O I
10.1200/JCO.2016.34.15_suppl.e21597
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e21597
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Effectiveness and safety of ferric carboxymaltose to treat iron deficiency anemia in cancer patients.
    Aktas, Burak Yasin
    Kayku, Vildan Eda
    Aslan, Alma
    Kertmen, Neyran
    Dizdar, Omer
    Yalcin, Suayib
    Aksoy, Sercan
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Treatment of anemia in cancer patients undergoing chemotherapy with intravenous ferric carboxymaltose without erythropoiesis-stimulating agents
    Abdel-Razeq, Hikmat
    Saadeh, Salwa S.
    Malhis, Razan
    Yasser, Sameer
    Abdulelah, Hazem
    Eljaber, Rana
    Kleib, Amer
    Ismael, Rouba
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [3] Intravenous ferric carboxymaltose for anaemia in pregnancy
    Froessler, Bernd
    Collingwood, Joshua
    Hodyl, Nicolette A.
    Dekker, Gustaaf
    BMC PREGNANCY AND CHILDBIRTH, 2014, 14
  • [4] Intravenous ferric carboxymaltose for the treatment of anemia in chronic renal disease
    Merino, J. L.
    Bueno, B.
    Campos, M. A.
    Amezquita, Y.
    REVISTA CLINICA ESPANOLA, 2014, 214 (05): : 282 - 283
  • [5] Intravenous ferric carboxymaltose for the treatment of iron deficiency anaemia - reply
    Cancado, Rodolfo Delfini
    Friedrisch, Joao Ricardo
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (01) : 100 - 101
  • [6] Intravenous ferric carboxymaltose for anaemia in pregnancy
    Bernd Froessler
    Joshua Collingwood
    Nicolette A Hodyl
    Gustaaf Dekker
    BMC Pregnancy and Childbirth, 14
  • [7] Hypophosphatemia After Intravenous Ferric Carboxymaltose in Heart Transplant Patients
    Santulario-Verdu, L.
    Echeverry-Navarrete, E.
    Diez-Lopez, C.
    Canedo-Castelo, M.
    Juvany-Roig, R.
    Garcia-Romero, E.
    Roca-Elias, J.
    Manito-Lorite, N.
    Gonzalez-Costello, J.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S220 - S221
  • [8] Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia
    Bregman, David B.
    Goodnough, Lawrence T.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (02) : 48 - 60
  • [9] Severe hypophosphatemia after ferric carboxymaltose intravenous treatment: Case series
    Nunez Montero, Melani
    Montane Esteva, Eva
    Hladun Alvaro, Olga
    Jimenez Capel, Yolanda
    Joaquin Ortiz, Clara
    Ramos Rodas, Analia
    Morales Triado, Anna
    Sancho Cerro, Ana
    Martinez Couselo, Silvia
    Guardiola Ponti, Helena
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2022, 130 : 28 - 29
  • [10] Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia: Letter to Editor
    Kanshaiym, Sakiyeva
    Zhurabekova, Gulmira
    Abdelazim, Ibrahim A.
    Starchenko, Tatyana
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (01) : 98 - 99